Evidence status: CURRENT SEPARATE STATUTORY TREATMENT-AGREEMENT FRAMEWORK. Indiana also requires treatment agreements in office-based opioid treatment for opioid use disorder. That requirement is separate from the chronic-pain opioid agreement documented elsewhere in this library.
Office-based opioid treatment
Indiana Code §12-23-20-2 requires a health-care provider prescribing in an office-based opioid-treatment setting to obtain informed consent and establish a treatment agreement with the patient.
Minimum agreement contents
The office-based opioid-treatment agreement must include at least:
- Treatment goals.
- Consent to drug-monitoring testing.
- Prescribing policies requiring medication to be taken as prescribed and prohibiting sharing or selling medication.
- Disclosure of other controlled substances or medications and alcohol consumed by the patient.
- Consent to random pill counts.
- Reasons office-based opioid treatment may be changed or discontinued.
Additional office-based treatment duties
The statute separately requires assessment, substance-use and mental-health history, toxicology screening, recurring INSPECT review, treatment-progress documentation, pregnancy-related care where applicable, overdose-intervention medication when buprenorphine is initiated, and an ongoing psychosocial-support component.
Do not confuse this with the pain contract
The chronic-pain Treatment Agreement under 844 IAC 5-6 regulates opioid prescribing for chronic pain after specified thresholds are met. Indiana Code §12-23-20-2 regulates office-based treatment of opioid use disorder. The agreement language is similar, but the treatment purpose, legal authority, patient population, and monitoring rules are different.
Primary source
Reviewed: October 4, 2026.
Evidence boundary: This page exists to prevent an opioid-use-disorder treatment agreement from being misclassified as a chronic-pain Contract for Care.